...
首页> 外文期刊>Journal of clinical laboratory analysis. >Captopril apparently increase and cisplatin apparently decrease human albumin concentration in artificial urinary solutions
【24h】

Captopril apparently increase and cisplatin apparently decrease human albumin concentration in artificial urinary solutions

机译:卡托普利显然增加,顺铂显然降低了人工尿液溶液中的人白蛋白浓度

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Measurement of urinary albumin (HSA) is very important in diagnostic of kidney diseases. Much less is known about the possible impact of substances present in urine together with albumin on the results of measurements. Methods We investigated the effect of the presence of captopril and cisplatin in the solution on the result of the determination of HSA by native polyacrylamide gel electrophoresis. Protein conformation in the absence and presence of the drugs was examined using Fourier Transform Infrared Spectroscopy (FTIR). Results The presence of captopril apparently increases HSA concentration while cisplatin causes an apparent decrease in the HSA concentration. The presence of both drugs also influence the secondary structure forms of HSA albumin investigated by FTIR. Conclusion Both drugs tested in the concentration of human use can have an impact on the results of determination of albumin in urine which can influence clinical decision.
机译:尿白蛋白(HSA)的背景测量在肾脏疾病的诊断中非常重要。 关于尿液中存在的可能影响与白蛋白在测量结果上的可能影响更少。 方法采用天然聚丙烯酰胺凝胶电泳研究了对溶液在溶液中的溶液中的效果。 使用傅里叶变换红外光谱(FTIR)检查在不存在和存在药物中的蛋白质构象。 结果卡托普利的存在显然增加了HSA浓度,而顺铂导致HSA浓度的表观降低。 两种药物的存在也影响了通过FTIR研究的HSA白蛋白的二级结构形式。 结论两种在人类用途中测试的药物可能对尿液中白蛋白的测定结果产生影响,这会影响临床决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号